Ten years ago, we published the 'rule of three' (RO3) 3 — a set of guidelines describing desirable physicochemical properties for molecules in FBDD screening collections, which we believed at the time ...
Fragment-based drug discovery (FBDD) is playing an increasingly important part in delivering candidates to the clinic. Compared with screens of lead- or drug-sized molecules, fragments allow for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback